Decode Genetics related Press Releases
deCODE genetics, Together with Academic Collaborators and Illumina, Discovers Genetic Risk Factor for Skin, Prostate and Brain C
REYKJAVIK, Iceland, September 25, 2011 /PRNewswire/ -- Scientists at deCODE Genetics and academic collaborators from Iceland, The Netherlands, Spain, Denmark, Germany, Sweden, the USA, the UK and Read more...
deCODE Discovers Major Genetic Risk Factor for the Most Common Form of Glaucoma
REYKJAVIK, Iceland, September 13, 2010 /PRNewswire-FirstCall/ -- - SNP on Chromosome 7 is Rare Among Chinese but Confers Five-Fold Increase in Risk; Underscores Importance of Analyzing Risk Factors Read more...
Announcing the New deCODE
Reykjavik, ICELAND, January 21, 2010 - deCODE genetics ehf today emerged as a newly financed, private company focused on advancing the science of human genetics and its application to products and
Read more...deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention REYKJAVIK, Iceland, Feb. 6 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: Read more...
deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis
deCODE Discovers Common Genetic Variations Contributing to Low Bone Mineral Density and Risk of Osteoporosis REYKJAVIK, Iceland, December 15 deCODE REYKJAVIK, Iceland, December 15
Read more...Major deCODE-led Study Underscores Role of the Brain in Obesity
REYKJAVIK, Iceland, December 14 /PRNewswire-FirstCall/ -- In one of the largest studies of its kind, a multinational team led by scientists from deCODE genetics (Nasdaq:DCGN) today report the Read more...
Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack
Positive Results from Phase IIa Study Pave Way for Phase IIb Trial of DG051 for the Prevention of Heart Attack Reykjavik, ICELAND, January 9, 2008 – deCODE genetics (Nasdaq:DCGN) today announced Read more...
deCODE Launches deCODEme(TM)
Name:
PR Newswire
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
